NEUCA S.A. (WSE:NEU)

Revenue by Segment

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Wholesale Distribution of Drugs (Including Marketing Services)	12.54B	11.59B	10.97B	10.75B	9.60B
Wholesale Distribution of Drugs (Including Marketing Services) Growth	8.15%	5.64%	2.12%	11.93%	5.79%
Production of Pharmaceuticals	443.63M	365.81M	357.32M	315.99M	201.06M
Production of Pharmaceuticals Growth	21.27%	2.38%	13.08%	57.17%	50.68%
Medical Operator	521.33M	457.52M	361.84M	235.69M	144.78M
Medical Operator Growth	13.95%	26.44%	53.52%	62.80%	29.28%
Clinical Research	460.33M	451.63M	403.78M	196.05M	133.56M
Clinical Research Growth	1.93%	11.85%	105.96%	46.79%	84.84%
Insurance Business	212.79M	192.81M	134.95M	102.54M	24.68M
Insurance Business Growth	10.37%	42.87%	31.61%	315.53%	-
Unallocated Adjustments	-530.81M	-447.52M	-417.82M	-363.17M	-239.68M
Total	13.64B	12.61B	11.81B	11.23B	9.86B
Total Growth	8.18%	6.76%	5.17%	13.87%	6.70%

Revenue by Geography

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
European Union	13.37B	12.36B	11.58B	-	-
European Union Growth	8.18%	6.76%	-	-	-
Outside The European Union	272.87M	252.24M	236.25M	-	-
Outside The European Union Growth	8.18%	6.76%	-	-	-
Poland	-	-	-	11.23B	9.86B
Poland Growth	-	-	-	13.87%	6.70%
Total	13.64B	12.61B	11.81B	11.23B	9.86B
Total Growth	8.18%	6.76%	5.17%	13.87%	6.70%

Source: S&P Global Market Intelligence.